US › Healthcare

Humana Inc (HUM)

US · Healthcare · Healthcare Plans

$362.16-3.30%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$40.87B
Revenue YoY
+26.2%
Net profit
$693.0M
Profit YoY
+27.2%
EPS
$6.27
EPS estimate
$6.22
Net margin
1.7%

EPS came in at 6.27 against a street estimate of 6.22 — a beat of 0.8%.

Key statistics

Market cap
$44.97B
P/E
35.4
Forward P/E
40.0
P/B
2.27
Book value
$154.75
EPS (TTM)
$10.59
Dividend yield
0.97%
52-week high
$428.88
52-week low
$161.90
50-day MA
$367.65
200-day MA
$265.26
Beta
0.74

Analyst view

Analysts rate Humana Inc a buy (9 buy, 17 hold, 0 sell out of 26) with an average price target of $347.96.

Shareholding

Insiders
0.21%
Institutions
99.91%

Largest institutional holders

FundStake
Vanguard Group Inc11.88%
Dodge & Cox9.48%
BlackRock Inc8.49%
Vanguard Capital Management, LLC6.53%
Vanguard Portfolio Management, LLC4.84%
Pzena Investment Management, LLC4.56%
State Street Corp4.54%
Massachusetts Financial Services Company3.73%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Humana Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.